191 related articles for article (PubMed ID: 23108091)
21. Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB × NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells.
Wang X; Oates JC; Helke KL; Gilkeson GS; Zhang XK
Arthritis Rheumatol; 2021 Aug; 73(8):1478-1488. PubMed ID: 33559345
[TBL] [Abstract][Full Text] [Related]
22. Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis.
Dai C; Liu Z; Zhou H; Li L
Chin Med J (Engl); 2001 Aug; 114(8):864-8. PubMed ID: 11780369
[TBL] [Abstract][Full Text] [Related]
23. The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis.
Costa-Reis P; Russo PA; Zhang Z; Colonna L; Maurer K; Gallucci S; Schulz SW; Kiani AN; Petri M; Sullivan KE
Arthritis Rheumatol; 2015 Sep; 67(9):2415-26. PubMed ID: 26016809
[TBL] [Abstract][Full Text] [Related]
24. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.
Zhai JX; Zhang ZX; Feng YJ; Ding SS; Wang XH; Zou LW; Ye DQ
Mol Biol Rep; 2012 Jun; 39(6):6763-71. PubMed ID: 22318546
[TBL] [Abstract][Full Text] [Related]
25. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis.
Liu T; Xia L; Yao Y; Yan C; Fan Y; Gajendran B; Yang J; Li YJ; Chen J; Filmus J; Spaner DE; Zacksenhaus E; Hao X; Ben-David Y
Cell Death Dis; 2019 Feb; 10(2):117. PubMed ID: 30741932
[TBL] [Abstract][Full Text] [Related]
26. Monocyte chemoattractant protein-1 activates a regional Th1 immunoresponse in nephritis of MRL/lpr mice.
Shimizu S; Nakashima H; Karube K; Ohshima K; Egashira K
Clin Exp Rheumatol; 2005; 23(2):239-42. PubMed ID: 15895897
[TBL] [Abstract][Full Text] [Related]
27. Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis.
Ichimura Y; Asano Y; Akamata K; Takahashi T; Noda S; Taniguchi T; Toyama T; Aozasa N; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
Arch Dermatol Res; 2014 May; 306(4):331-8. PubMed ID: 24292093
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of macrophage inflammatory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis.
Tam FW; Karkar AM; Smith J; Yoshimura T; Steinkasserer A; Kurrle R; Langner K; Rees AJ
Kidney Int; 1996 Mar; 49(3):715-21. PubMed ID: 8648912
[TBL] [Abstract][Full Text] [Related]
29. Acetylation impacts Fli-1-driven regulation of granulocyte colony stimulating factor.
Lennard Richard ML; Brandon D; Lou N; Sato S; Caldwell T; Nowling TK; Gilkeson G; Zhang XK
Eur J Immunol; 2016 Oct; 46(10):2322-2332. PubMed ID: 27431361
[TBL] [Abstract][Full Text] [Related]
30. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
31. Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis.
Timoshanko JR; Kitching AR; Semple TJ; Holdsworth SR; Tipping PG
J Am Soc Nephrol; 2005 Sep; 16(9):2646-56. PubMed ID: 16033860
[TBL] [Abstract][Full Text] [Related]
32. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis.
Rovin BH; Rumancik M; Tan L; Dickerson J
Lab Invest; 1994 Oct; 71(4):536-42. PubMed ID: 7967509
[TBL] [Abstract][Full Text] [Related]
33. EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo.
Sohn EJ; Li H; Reidy K; Beers LF; Christensen BL; Lee SB
Cancer Res; 2010 Feb; 70(3):1154-63. PubMed ID: 20103643
[TBL] [Abstract][Full Text] [Related]
34. Platelet-derived growth factor (PDGF)-BB-mediated induction of monocyte chemoattractant protein 1 in human astrocytes: implications for HIV-associated neuroinflammation.
Bethel-Brown C; Yao H; Hu G; Buch S
J Neuroinflammation; 2012 Dec; 9():262. PubMed ID: 23198981
[TBL] [Abstract][Full Text] [Related]
35. Expression of monocyte chemoattractant protein-1 in experimental crescentic glomerulonephritis in rats.
Sekiguchi M; Natori Y; Iyonaga K; Takeya M; Natori Y
J Lab Clin Med; 1997 Feb; 129(2):239-44. PubMed ID: 9016861
[TBL] [Abstract][Full Text] [Related]
36. Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice.
Bird JE; Giancarli MR; Kurihara T; Kowala MC; Valentine MT; Gitlitz PH; Pandya DG; French MH; Durham SK
Kidney Int; 2000 Jan; 57(1):129-36. PubMed ID: 10620194
[TBL] [Abstract][Full Text] [Related]
37. Transcription factor activating protein-2beta: a positive regulator of monocyte chemoattractant protein-1 gene expression.
Kondo M; Maegawa H; Obata T; Ugi S; Ikeda K; Morino K; Nakai Y; Nishio Y; Maeda S; Kashiwagi A
Endocrinology; 2009 Apr; 150(4):1654-61. PubMed ID: 19022887
[TBL] [Abstract][Full Text] [Related]
38. FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL/lpr Lupus Mouse Strain.
Sundararaj KP; Thiyagarajan T; Molano I; Basher F; Powers TW; Drake RR; Nowling TK
J Immunol; 2015 Dec; 195(12):5551-60. PubMed ID: 26538397
[TBL] [Abstract][Full Text] [Related]
39. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.
Shimizu S; Nakashima H; Masutani K; Inoue Y; Miyake K; Akahoshi M; Tanaka Y; Egashira K; Hirakata H; Otsuka T; Harada M
Rheumatology (Oxford); 2004 Sep; 43(9):1121-8. PubMed ID: 15213333
[TBL] [Abstract][Full Text] [Related]
40. [Langohuangping granule down-regulated monocyte chemoattractant protein-1 via suppressing nuclear factor kappa B signaling pathway in BXSB lupus nephritis mice].
Li GY; Lu XQ; Liu SX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1685-9. PubMed ID: 22384559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
